Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Kindly find enclosed investor presentation
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India PFA
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Kindly find enclosed
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation on financial results for FY24
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation on financial results for quarter ended December 31, 2024
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor presentation for Q2FY24
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investors presentation on Financial results for quarter ended June 30, 2023
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation Q4FY23 and FY23
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation Q3FY23
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation H1FY23 & Q2FY23